New CDC Guidelines: People at Risk for HIV Should Consider Truvada PrEP
Healthcare providers should advise people at “substantial risk” for HIV infection about pre-exposure prophylaxis (PrEP) using tenofovir/emtricitabine, or Truvada, according to new guidelines issued by the U.S. Centers for Disease Control and Prevention (CDC). This includes HIV negative people in an ongoing sexual relationship with HIV positive partners, gay or bisexual men who have had sex …
New CDC Guidelines: People at Risk for HIV Should Consider Truvada PrEP Read More »
